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Background. The purpose of this study was to deter-
mine (1) the role of emergency cardiopulmonary bypass
(CPB) after prolonged cardiac arrest and failed cardiopul-
monary resuscitation, and (2) the use of systemic hyper-
kalemia during CPB to convert intractable ventricular
fibrillation (VF).
Methods. Thirty-one pigs (34 ! 2 kg) underwent 15
minutes of cardiac arrest after induced VF, followed by
10 minutes of cardiopulmonary resuscitation–advanced
life support. Peripheral CPB was used if cardiopulmo-
nary resuscitation failed to restore stable circulation.
Damage was assessed by evaluating hemodynamics, bio-
chemical variables (creatine kinase-MB, neuron-specific
enolase), neurologic deficit score, and brain magnetic
resonance imaging.
Results. Cardiopulmonary resuscitation alone was suc-
cessful in only 19% (6 of 31 pigs). Cardiopulmonary
bypass was initiated in 81% of animals (25 of 31 pigs)
either for hypotension (5 of 25 pigs) or intractable VF (20
of 25 pigs). Defibrillation was successful in 7 of 20
animals during the first 10 minutes after initiating CPB.
Ventricular fibrillation persisted more than 10 minutes in
13 of 20 pigs, and animals were treated either with
repeated defibrillation (6 of 13 pigs) or with a potassium
bolus (7 of 13 pigs) to induce transient cardiac arrest.
Overall survival at 24 hours was 84% with cardiopulmo-
nary resuscitation (100% of pigs with hypotension; 71%
in CPB-VF < 10 minutes). Despite CPB, fatal myocardial
failure occurred after VF duration of more than 10 min-
utes in all pigs treated with electrical defibrillation,
whereas hyperkalemia allowed 100% cardioversion and
86% survival. Biochemical variables remained elevated
in all groups. Similarly, severe brain injury was present
in all animals as confirmed by neurologic deficit score
(197 ! 10) and magnetic resonance imaging.
Conclusions. Emergency CPB after prolonged cardiac
arrest improves survival and allows systemic hyperkale-
mia to convert intractable VF, but fails to reduce neuro-
logic damage.
(Ann Thorac Surg 2010;89:1972–80)
© 2010 by The Society of Thoracic Surgeons
Successful cardiopulmonary resuscitation (CPR) aftercardiac arrest (CA) is possible in approximately 20%
to 40%, yet survival is only 5% to 10% and the majority of
survivors have permanent brain damage [1]. Conversely,
survival rates of up to 50% can be achieved if CPR with
early defibrillation is provided within 4 to 5 minutes, but
is negligible if these critical time intervals double, with a
greater than 95% mortality in victims after prolonged
(unwitnessed) CA [2–5].
Cardiopulmonary bypass (CPB) expands the time win-
dow for successful resuscitation after CA when compared
with conventional CPR [6, 7], as 80% to 100% survival and
complete cardiac and neurologic recovery occur after 5 to
10 minutes of CA in dogs [7, 8]. Time is a critical factor, as
mortality increases substantially (approximately 80%)
and no neurologic recovery occurs after CPR-advanced
life support (CPR-ALS) after 12.5 minutes of no-flow CA
[9]. This is curtailed with CPB, with a 70% survival and
50% of dogs gaining consciousness after 12.5 minutes of
CA. However, after 15 minutes of CA, there is no survival
with CPR-ALS and even though CPB allows approxi-
mately 25% to 80% survival, it fails to prevent severe
neurologic damage [7, 10–12]. Furthermore, despite the
improvements conferred by CPB, intractable ventricular
fibrillation (VF) after prolonged CA remains a survival
barrier; it occurs in 20% to 50% of animals after CA arrest
of 15 minutes, and results in 100% mortality from cardio-
genic shock [7, 11, 13].
Although these findings imply that emergency CPB is
superior to CPR-ALS for resuscitation after prolonged
CA, none of these studies implemented a preceding CPR
interval that is mandatory in the clinical setting for before
CPB is initiated. The present study was aimed to assess
whether emergency normothermic CPB as a resuscita-
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tion tool can improve recovery after 15 minutes of CA
(simulating an unwitnessed arrest), when CPR-ALS is
ineffective. As a secondary objective, we tested the hy-
pothesis that potassium as a depolarizing cardioplegic
agent can offset intractable VF after prolonged CA unre-
sponsive to defibrillation, and improve survival of this
otherwise lethal cohort.
Material and Methods
The study was approved by the Institutional Animal
Research Committee of the University of California at
Los Angeles. All animals received humane care in com-
pliance with the 1996 NRC Guide for the Care and Use of
Laboratory Animals.
Thirty-one Yorkshire-Duroc pigs (35.2 ! 1.8 kg) were
premedicated with 15 mg/kg ketamine and 0.5 mg/kg
diazepam intramuscularly. Neuromuscular blockade was
achieved by a single pancuronium bolus (0.2 mg/kg). En-
dotracheal intubation anesthesia was maintained with in-
haled isoflurane (1.2% to 1.5%), using a volume-controlled
ventilator (Servo 900C, Siemens Elema, Solna, Sweden) at
12 to 14 breaths/min, 10 to 15 mL/kg tidal volume, and
adjusted to normalize arterial blood gases.
Heart rate and rhythm were determined by electrocar-
diography, arterial pressure using a catheter inserted
into the left internal thoracic artery, and pulmonary
artery pressure by a Swan-Ganz catheter (model 132F5,
Baxter Healthcare Corp, Irvine, CA) inserted through the
right subclavian vein. Cefazolin (30 mg/kg, GlaxoSmith-
Kline, Philadelphia, PA) was given every 8 hours, and
normal saline solution was infused intravenously at 5 to
10 mL · kg"1 · h"1. Body temperature was kept at 37°C
using a heating pad. Sterile incisions were performed to
expose the right femoral artery and right external jugular
vein.
Cardiac Arrest and Resuscitation Protocol
After baseline measurements, systemic heparinization
(300 IU/kg) was given before inducing CA. No-flow CA
was maintained for 15 minutes without ventilation after
inducing VF with a 60-Hz (4.5 A) alternating current
(AC-Fibrillator, Medtronic, Inc, Minneapolis, MN) stim-
ulus to the right ventricular endocardium using a cathe-
ter (Bard Electrophysiology, Lowell, MA) inserted
through the right subclavian vein.
The resuscitation protocol was initiated after 15 min-
utes of CA by using the American Heart Association
advanced cardiac life support algorithm (ALS) (http://
www.americanheart.org) [14] for 10 minutes, yielding 80
to 100 manual chest compressions per minute and bag
ventilation at 12 to 15 breaths/min. Defibrillation was
attempted after five cycles of CPR, with 200 J (Lifepak 9P,
Physio-Control Corp, Redmond, WA), and repeated after
every five CPR cycles with 300 to 360 J until spontaneous
circulation (ROSC) was restored. Intravenous epineph-
rine (0.02 to 0.04 mg/kg) was administered 2 minutes after
beginning CPR, and repeated every 2 to 5 minutes as
needed. Lidocaine (1 mg/kg) was given if a shockable
heart rhythm was present, and repeated until reaching
the maximal dosage (3 mg/kg). Cardiopulmonary resus-
citation intensity was adjusted to achieve a targeted
coronary perfusion pressure of greater than 15 mmHg as
indicated by the difference of diastolic arterial pressure
and central venous pressure.
Arterial (12F) and venous (19 to 21F) cannulas
(Medtronic, Inc) were inserted into the femoral artery
and right atrium (through the external jugular vein) and
connected to the CPB circuit during the CPR-ALS inter-
val. Extracorporeal circulation consisted of a membrane
oxygenator (Affinity NT 541, Medtronic, Inc), an arterial
roller pump (Sarns, Ann Arbor, MI), and a venous
centrifugal pump (Biopump BPX-80, Medtronic, Inc) for
active venous suction. The extracorporeal circuit was
primed with 800 mL of Plasma-Lyte (Baxter Healthcare
Corp), 700 mL of stored porcine packed donor blood,
heparin (100 IU/kg), and calcium chloride to maintain
normocalcemia (approximately 1.2 mmol/L).
Restoration of stable circulation (ROSC) during CPR-
ALS was defined as return of supraventricular rhythm
with the ability to maintain a mean arterial pressure
greater than 50 mm Hg for 1 minute. Cardiopulmonary
bypass was initiated when 10 minutes of CPR-ALS failed
to achieve ROSC, defined as (1) raising mean arterial
pressure greater than 50 mm Hg (CPB-Hypo), or (2)
persistence of ventricular fibrillation (CPB-VF), which
was further subdivided into three cohorts based on the
length and treatment of VF:
VF ! 10 min group: Cardioversion was achieved during
the first 10 minutes of CPB with countershocks (360 J)
repeated every 3 minutes on CPB.
VF # 10 min group: Animals with intractable VF persist-
ing past the initial 10 minutes on CPB were random-
ized to receive either repeated countershocks every 3
to 5 minutes (VF # 10 min), or a 15 mEq/L potassium
bolus (2mEq/mL) into the arterial line of theCPB circuit
for 10 to 20 seconds (VF # 10 min $ potassium).
Cardiopulmonary Bypass Management and
Postoperative Care
Peripheral CPB was established at approximately 300
mm Hg arterial partial pressure of oxygen, and flow was
adjusted (100 to 150 mL · kg"1 · min"1) to maintain an
arterial pressure of 50 to 70 mm Hg and a mixed venous
oxygen saturation of greater than 70%. Body temperature
was kept at 37°C. Arterial blood gases, electrolytes, and
hematocrit were measured every 15 to 30 minutes to
ensure optimal levels (Blood Gas System 288, Ciba Corn-
ing, Midfield, MA), and activated clotting time was kept
greater than 400 seconds. Discontinuation of CPB was
initiated when there was a stable heart rhythm for 30
minutes, and mean arterial pressure was greater than 50
mm Hg with or without inotropic (dopamine 5 to 10 %g ·
kg"1 · min"1) support.
Protamine was given to antagonize systemic hepa-
rinization, cannulas were removed, femoral vessels were
repaired, and all wounds were closed. Postoperative
inotropic support was adjusted to maintain mean arterial
pressure between 50 and 70 mm Hg. Animals were
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extubated when they were able to maintain normal
arterial partial pressures of oxygen and carbon dioxide
with spontaneous breathing. Animals were monitored
for 24 hours after CPB or for an equal period when CPB
was not used.
Hemodynamic and Biochemical Determinations
Hemodynamic measurements were made before induc-
tion of VF (baseline) and after discontinuation of CPB or
at equal time intervals in animals without CPB. Cardiac
output was determined by triplicate injections of 4°C cold
saline solution, and cardiac index and left ventricular stroke
work index were calculated using standard equations.
Arterial blood was sampled at baseline, after CPB, and
at 24 hours with samples centrifuged (1,000 & g) for 10
minutes and stored at "20°C until analysis. To mark
cardiac and brain injury, creatine kinase-MB activity was
assessed by the ultraviolet-spectrophotometric method
(Sigma Chemical Co, St. Louis, MO), and neuron-specific
enolase was quantified using an Enzyme Immunometric
Assay (SynX Pharma Inc, Toronto, ON) according to the
manufacturer’s recommendation.
Neurologic Deficit Score and Magnetic Resonance
Imaging
Neurologic assessment was performed at 4 and 24 hours
after CPB using a species-specific behavior scale, and
seizure activity was evaluated [15, 16]. The neurologic
deficit score assesses five neurologic components (cranial
nerves, motor and sensory, respiration, consciousness,
behavior) with a score of 0 to 100 in each category: 0 '
normal, 500 ' brain death. Neurologic deficit score was
independently assessed by 2 laboratory individuals, and
the mean value was recorded if scores were different.
After assessment of the 24-hour neurologic deficit
score, 4 CPB survivors underwent brain magnetic reso-
nance imaging (MRI) after sedation and endotracheal
intubation. Studies were performed on a 3.0-T magnetic
resonance system (Magnetom Trio, Siemens Medical
Solutions, Malvern, PA), using an axial T2-weighted
(T2W) MRI scan. Tissue hyperintensity on T2W turbo
spin echocardiography sequence was used to define
completed acute infarction when the diffusion scan was
positive. Axial diffusion-weighted MRI was performed to
identify sites of acute ischemia when the T2W sequence
was normal, or completed infarction when T2W hyperin-
tensity was present. A three-dimensional time of flight
magnetic resonance angiogram was used to demonstrate
patency of the cerebral vessels, and brain perfusion
sequence was obtained using gadodiamide (Omniscan,
GE Amersham Health Inc, Princeton, NJ). Scans were
evaluated by an experienced neuroradiologist (P.V.).
Statistical Analysis
Datawere expressed asmean! standard error of themean.
Two-way analysis of variance with Fisher’s least significant
difference procedure for post-hoc repeated measurements
was used to analyze intragroup and intergroup differences.
Perioperative characteristics of groups were analyzed by
Student’s t test for continuous data and (2 or Fisher’s exact
test for categorical data. Probability values less than 0.05
were considered statistically significant.
Results
Baseline hemodynamic and blood gas data were similar
in all animals. The VF amplitude was 0.64 ! 0.04 mV
immediately after VF induction, and declined to 0.33 !
0.05 mV (52% of baseline; p ) 0.05) at 7.5 minutes, and
was almost abolished at 15 minutes (0.20 ! 0.03 mV; 31%
of baseline; p ) 0.05). Cardiopulmonary resuscitation-
ALS consistently produced coronary perfusion pressure
greater than 15 mm Hg with average coronary perfusion
pressure of 29 ! 3, 28 ! 6, and 31 ! 5 mm Hg at 3, 6, and
10 minutes of CPR, respectively.
Successful defibrillation was achieved in 11 of 31 animals
(35%) during CPR-ALS, but ROSC was possible in only 6
(19%; ROSC group; Fig 1). Consequently, 81% of animals
were subjected to emergency CPB after 10 minutes of
CPR-ALS, 5 with persistent hypotension (16%; CPB-Hypo)
and 20with intractable VF (65%; CPB-VF). Seven of 20 (35%)
animals with intractable VF were successfully cardioverted
during the first 10 minutes of CPB (VF ! 10 min), whereas
13 of 20 pigs remained in VF more than 10 minutes. Within
this cohort, 6 animals underwent repeated defibrillation
until successful cardioversion, whereas electromechanical
quiescence was quickly achieved in the remaining 7 pigs
after delivering potassium (average dose, 14.7! 1.7 mEq/L)
through the CPB arterial line. Systemic hyperkalemia re-
sulted in a brief interval of asystole (20 to 60 seconds),
followed by initial bradycardia, with recovery to a normal
heart rate in all but 1 animal that experienced recurrent VF
that was defibrillated by one electrical shock.
Total epinephrine dose, number of shocks during CPR-
ALS, time until defibrillation, total CPB time, and inotropic
Fig 1. Resuscitation outcome of animals (n ' 31) subjected to 15
minutes of cardiac arrest (CA) followed by 10 minutes of cardiopul-
monary resuscitation–advanced life support (CPR-ALS). Note: CPR-
ALS restored cardiac heart rhythm in 35% of animals, whereas in
65% cardiopulmonary bypass (CPB) was established for refractory
ventricular fibrillation (VF). (Hypo ' hypotension.)
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support requirements are summarized in Table 1. Total
epinephrine dose and number of defibrillations during
CPR were similar in all groups. More total shocks were
needed when CPB was initiated for intractable VF and,
especially, in the CPB-VF greater than 10 minutes group
without potassium, in which 11.1! 0.8 countershocks were
required during CPB (p ) 0.05), and 1 animal with pro-
longed VF could not be weaned from CPB owing to cardiac
failure. Conversely, all animals in the CPB-Hypo group and
19 of 20 placed on CPB for persistent VF could be weaned
from CPB. However, duration on CPB differed in regard to
intractable VF management, with earlier CPB discontinua-
tion being possible in VF less than or equal to 10 minutes
and VF greater than 10 minutes plus potassium groups.
Hemodynamic and Biochemical Measurements
As shown in Table 2, resuscitation on CPB increased heart
rate and mean pulmonary artery pressure and decreased
left ventricular stroke work index (p ) 0.05), but did not
change cardiac index or mean arterial blood pressure.
However, myocardial failure occurred after prolonged VF
(CPB-VF # 10 min), with reduced mean arterial pressure,
cardiac index, and left ventricular stroke work index (p )
0.05). These adverse hemodynamic consequences were off-
set by inducing hyperkalemic arrest with potassium, as CPB
duration was lowered to 99 ! 9 minutes, fewer shocks
(1.8! 0.3) were needed compared with the VF greater than
10 minutes group without potassium (Table 1), and post-
CPB hemodynamic recoverywas similar to all other groups.
Creatine kinase-MB and neuron-specific enolase levels
were elevated in all groups after CA (Table 3), implying
severe myocardial and brain cellular damage. Biochem-
ical markers of cardiac and cerebral injury tended to be
higher after prolonged VF (CPB-VF # 10 min), but
differences did not reach statistical significance. In the
CPB-VF greater than 10 minutes groups, potassium blood
Table 1. Perioperative Variables After Cardiac Arresta
Condition N
Epinephrine
(%g/kg)
Time to Defibrillation
(min)
No. of Shocks
CPB Time
(min)
Dopamine
(n, %)CPR CPB
ROSC 6 68 ! 4 6.5 ! 0.8 4.0 ! 0.4 4 (67%)
CPB-Hypo 5 64 ! 5 5.4 ! 1.0 3.8 ! 0.6 66 ! 4 5 (100%)
CPB-VF
VF ! 10 min 7 77 ! 3 19.4 ! 0.4b 5.1 ! 0.5 2.1 ! 0.3 84 ! 8 5 (71%)
VF # 10 min 6 74 ! 2 44.4 ! 7.8b,c 5.7 ! 0.5 5.5 ! 0.8c 155 ! 19b,c 6 (100%)
VF # 10 min $ potassium 7 76 ! 2 20.1 ! 0.4b 5.8 ! 0.4 1.8 ! 0.3 99 ! 9b 4 (57%)
a Data are mean ! standard error of the mean. b p ) 0.05 compared with the ROSC or CPB-Hypo. c p ) .05 compared with VF ! 10 minutes or
VF # 10 minutes $ potassium.
CPB ' cardiopulmonary bypass; CPR ' cardiopulmonary resuscitation; Hypo ' hypotension; ROSC ' return of spontaneous circula-
tion; VF ' ventricular fibrillation.
Table 2. Hemodynamic Dataa
Condition
HR
(beats/min)
MAP
(mm Hg)
MPAP
(mm Hg)
PCWP
(mm Hg)
CI
(L · min"1 · m"2)
LVSWI
(g · m/m2)
Baseline
ROSC 83 ! 5 75! 4 15 ! 1 9! 1 3.4 ! 0.4 39 ! 4
CPB-Hypo 94 ! 9 74! 4 15 ! 2 9! 1 3.4 ! 0.2 34 ! 3
CPB-VF
VF ! 10 min 90 ! 4 75! 5 15 ! 2 9! 1 3.9 ! 0.5 38 ! 9
VF # 10 min 89 ! 8 75! 3 18 ! 1 10! 1 3.8 ! 0.4 37 ! 3
VF # 10 min $ potassium 94 ! 4 74! 3 18 ! 1 11! 1 3.7 ! 0.3 35 ! 2
After CPB
ROSC 197 ! 4b 75 ! 4 25 ! 2b 9 ! 1 3.3 ! 0.4 16 ! 3b
CPB-Hypo 190 ! 5b 69 ! 6 27 ! 4b 10 ! 2 3.4 ! 0.4 15 ! 3b
CPB-VF
VF ! 10 min 185 ! 9b 76 ! 5 30 ! 2b 10 ! 1 4.1 ! 0.5 19 ! 2b
VF # 10 min 199 ! 4b 55 ! 6b,c 28 ! 2b 9 ! 2 2.3 ! 0.4b,c 8 ! 2b,c
VF # 10 min $ potassium 195 ! 7b 75 ! 3 28 ! 2b 10 ! 2 3.8 ! 0.3 18 ! 4
a Data are mean ! standard error of the mean. b p ) 0.05 compared with baseline values. c p ) 0.05 compared with VF ! 10 min and VF # 10 min
$ potassium.
CI ' cardiac index; CPB ' cardiopulmonary bypass; HR ' heart rate; Hypo ' hypotension; LVSWI ' left ventricular stroke work
index; MAP'mean arterial pressure; MPAP'mean pulmonary artery pressure; PCWP' pulmonary capillary wedge pressure; ROSC'
return of spontaneous circulation; VF ' ventricular fibrillation.
1975Ann Thorac Surg LIAKOPOULOS ET AL
2010;89:1972–80 CPB AFTER PROLONGED CARDIAC ARREST
A
D
U
LT
C
A
R
D
IA
C
 by Nikola Hristov on October 2, 2010 ats.ctsnetjournals.orgDownloaded from 
concentrations (Fig 2) were higher after potassium bolus
injection compared with the no treatment group, with
levels returning to normal in both groups by the time
CPB was discontinued.
Survival
Twenty-four–hour survival was 83% (5 of 6 pigs) after
CPR-ALS and 64% (16 of 25 pigs) with CPB (Table 4). In
the CPB cohort, 100% of animals survived when hypo-
tension was the reason for CPB. In contrast, 24-hour
survival was 71% (5 of 7 pigs) if VF was successfully
converted within 10 minutes (CPB-VF! 10 min), whereas
mortality was 100% (6 of 6 pigs) if successful defibrillation
was not achieved after 10 minutes (VF # 10 min). Con-
versely, 6 of 7 animals survived in the VF greater than 10
minutes plus potassium group, resulting in 86% survival
(p ' 0.01 versus VF # 10 min). Cardiogenic shock with
severe hypotension was responsible for all deaths.
Neurologic Deficit Score and Magnetic Resonance
Imaging
Neurologic deficit score was highest at 4 hours, averaging
220 ! 9 for all survivors (Table 4), and improved slightly
to 197 ! 10 by 24 hours (p ) 0.05), but did not differ
among groups. All animals were conscious and breathing
spontaneously but none could sit, stand, walk, eat, or
drink. Generalized clonic seizures occurred in 71% of
survivors.
Contrast-enhanced magnetic resonance angiography
demonstrated normal, patent cerebral arteries in all an-
imals and no intracranial bleeding, and brain perfusion
sequences showed no abnormalities. In the T1-weighted
sequence the cerebral cortical mantle, brainstem, and
cerebellum were normal with no appreciable mass effect
or brain swelling. High T2W signal intensity was present
in the basal ganglia, including the globus pallidus (4 of 4
animals), putamen (4 of 4 animals), and nucleus caudatus
(2 of 4 animals), consistent with anoxic or hypoxic brain
injury (ie, infarction; Fig 3). Furthermore, the thalamus,
Table 3. Biochemical Dataa
Condition
CK-MB (U/mL) NSE (ng/mL)
Baseline After CPB 24 Hours Baseline After CPB 24 Hours
ROSC 24 ! 1 120 ! 13b 113 ! 20b 5.6 ! 0.1 14.4 ! 0.6b 16.4 ! 0.9b
CPB-Hypo 23 ! 2 125 ! 18b 120 ! 21 5.5 ! 0.2 15.1 ! 0.5b 16.3 ! 0.7b
CPB-VF
VF ! 10 min 24 ! 1 132 ! 13b 128 ! 19b 5.6 ! 0.1 15.8 ! 0.6b 17.2 ! 0.9b
VF # 10 min 27 ! 2 162 ! 13b — 5.4 ! 0.1 16.5 ! 0.6b —
VF # 10 min $ potassium 25 ! 1 123 ! 11b 121 ! 11b 5.4 ! 0.2 15.3 ! 0.7b 17.0 ! 1.3b
a Biochemical markers of myocardial and neurologic injury were uniformly elevated in all groups after prolonged arrest and CPB and at 24 hours. Note:
No biochemical variables could be obtained after prolonged VF on CPB (CPB-VF # 10 min) owing to 100% mortality. Data are mean ! standard error
of the mean. b p ) 0.05 compared with baseline values.
CK-MB'MB fraction of creatine kinase; CPB' cardiopulmonary bypass; Hypo' hypotension; NSE' neuron-specific enolase; ROSC'
return of spontaneous circulation; VF ' ventricular fibrillation.
Fig 2. Mean potassium plasma concentrations (mEq/L) in animals
with or without receiving a potassium bolus after 10 minutes on car-
diopulmonary bypass (CPB). Note the elevated potassium levels after
sudden cardiac death and cardiopulmonary resuscitation–advanced
life support. Furthermore, animals receiving potassium had higher
potassium concentrations at 15 to 60 minutes on cardiopulmonary
bypass when compared with untreated animals. Data are mean !
standard error of the mean. *p ) 0.05 compared with baseline val-
ues (base); #p ) 0.05 compared with untreated animals.
Table 4. Survival, Neurologic Deficit Score, and Seizure
Ratea
Condition
Survival
(n/%)
NDS
Seizures
(n/%)4 h 24 h
ROSC 5/6 (83%) 224 ! 20 195 ! 16 3 (60%)
CPB-Hypo 5/5 (100%) 211 ! 29 198 ! 24 3 (60%)
CPB-VF
VF ! 10 min 5/7 (71%) 223! 12 197 ! 12 4 (80%)
VF # 10 min 0/6 (0%)b — — —
VF # 10 min $
potassium
6/7 (86%) 219 ! 16 189 ! 25 5 (83%)
a Data are mean ! standard error of the mean. b p ) 0.05 compared
with VF ! 10 min and VF # 10 min $ potassium.
CPB ' cardiopulmonary bypass; Hypo ' hypotension; NDS '
neurologic deficit score; ROSC ' return of spontaneous circula-
tion; VF ' ventricular fibrillation.
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cerebellum, and portions of the brainstem were affected
in 2 of 4 animals, but none exhibited cortical infarction.
Comment
Hemodynamic recovery and survival were markedly im-
proved by using emergency CPB after the otherwise
lethal injury of 15 minutes of CA, simulating an unwit-
nessed CA. Only 19% successful resuscitation occurred
after conventional CPR-ALS, whereas CPB (1) aug-
mented post-CA hypotension, and (2) allowed conver-
sion of intractable VF. Consequently, temporary CPB
achieved 64% survival in animals that would otherwise
have succumbed with CPR-ALS alone. Prompt defibril-
lation is an important element for recovery, as VF greater
than 10 minutes resulted in 100% mortality. Conversely,
survival was 71% when cardioversion was successful
during the first 10 minutes on CPB, and 86% when
systemic potassium was used to gain defibrillation on
CPB. Unfortunately, improving cardiac survival did not
offset the poor neurologic recovery.
Three keynotes to treatment include recognizing the
role of CPB to overcome myocardial stunning after pro-
longed CA with CPR-ALS [4], using transient hyperkale-
mia on CBP to convert intractable VF, and insights into
improving brain recovery. Studies show that less than 10
minutes of experimental CA followed by normothermic
CPB results in almost complete myocardial and neuro-
logic recovery [7, 8]. Conversely, after 15 minutes of CA,
negligible (approximately 15%) survival has been re-
ported with CPR-ALS alone [7, 10, 12], and this finding is
consistent with the 19% survival reported in our model.
Although CPB allowed 64% survival after unsuccessful
CPR-ALS, it failed to prevent impaired neurologic recov-
ery and thus agrees with previous CPB reports [7, 10–12].
Our model differed from them because 15 minutes of CA
was followed by CPR-ALS, a clinically imperative inter-
val to allow the time needed for peripheral cannulation
necessary for CPB.
The logic underlying our model of using a period of 15
minutes CA followed by 10 minutes of CPR-ALS relates
to (1) the inherent delay in initiating CPR in unwitnessed
arrest, or (2) inadequate initial CPR owing to untrained
bystanders, as shown in a recent report of 99.4% mortal-
ity, if arrival of a trained resuscitation team was delayed
greater than 20 minutes [17]. Although minimal delay in
CPR may exist in hospitals with trained teams, imple-
mentation of CPB requires a 10- to 15-minute period of
CPR-ALS to allow for rapid surgical or percutaneous
access of femoral vessels [18, 19]. A recent systematic
review of 54 trials emphasizes the value of emergency
CPB for treatment of CA [6]. Among 675 patients receiv-
ing CPB for CA, 72% could be weaned successfully off
CPB with a 43% survival to hospital discharge, without
reporting neurologic outcomes of survivors [6]. Consis-
tent with this, up to 40% survival of patients has been
reported when CPB was established within the first 20 to
30 minutes of CPR-ALS [20, 21]. More importantly, simul-
taneously correcting the underlying cardiac disease that
occurs in greater than 60% of CA patients resulted in an
approximately 40% to 80% survival with more than 90%
of patients having complete neurologic recovery despite
CPR-ALS intervals of longer than 40 minutes [19, 22].
Cardiopulmonary bypass was also a predictor of mor-
tality in our study, as survival was 83% if animals were
subjected to CPB because of persistent hypotension or VF
less than 10 minutes. Conversely, 100% mortality from
myocardial dysfunction occurred after prolonged VF. The
cardiac consequences of prolonged VF include increased
myocardial oxygen consumption, depletion of high-energy
phosphates, and calcium overload, resulting in myocardial
stunning, ischemic contracture, and necrosis [2]. Further-
Fig 3. Axial T2-weighted slices at the level of the basal ganglia from the same subject. Note the hyperintensity in the caudate, globus pallidus,
and putamen in the T2 sequence (A) that appears with an increased diffusion signal in the diffusion-weighted image sequence (B), suggesting
symmetric hypoxic injury (white arrows). These zones are also accompanied by a hypointensity in the axial sequences (C), indicating true tis-
sue ischemia with completed infarction of the basal ganglia.
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more, CPR and electrical shocks become ineffective with
time [4, 23] and repeated defibrillation with higher accu-
mulated energy accentuate myocardial injury that wors-
ens post-CA myocardial function and outcome [24]. The
high mortality with intractable VF is consistent with
previous reports after prolonged CA, where mortality
was also 100% [11, 13]. Conversely, the 71% survival after
early cardioversion (VF) 10 min), or 86% after potassium
depolarization, supports the importance of CPB to main-
tain perfusion pressure and early treatment to promptly
return spontaneous rhythm.
Use of potassium to limit the myocardial causes of
mortality after CA borrows from cardiac surgery in which
a warm blood cardioplegic reperfusate (“hot shot”) is
delivered during CPB [25]. It is also supported by two
clinical studies in witnessed CA patients with prolonged
VF unresponsive to CPR-ALS, in which CPB was subse-
quently followed by corrective cardiac surgery using a
controlled, substrate-enriched hyperkalemic cardiople-
gic reperfusion, resulting in excellent post-CA myocar-
dial recovery and approximately 80% survival [22, 26].
Thus, systemic potassium administration during CPB
initiates a novel treatment option for refractory VF after
prolonged CA.
Nonetheless, the capacity to restore satisfactory hemo-
dynamics in otherwise fatal intractable VF using CPB and
potassium addresses only the myocardial aspect of sur-
vival. Outcomes also depend on avoidance of damage to
other organs, especially the brain. Clinical neurologic
score marginally improved between 4 and 24 hours, with
MRI and neuron-specific enolase confirming severe neu-
rologic damage with lesions in the basal ganglia, thala-
mus, cerebellum, and brainstem. Similar MRI findings
are reported clinically after prolonged CA (#6 min), in
which increased diffusion-weighted signal intensity oc-
curred in these same brain regions [27]. Hence, CPB as a
resuscitative tool for unwitnessed CA successfully sal-
vages the heart, but fails to limit neurologic injury.
Modifying the potassium levels during CPBmay reflect
only the first step into adjusting the initial reperfusate
delivered by the CPB prime to counteract myocardial,
brain, and other organ injury. Subsequent alteration of
the pump prime and rapid CPB-assisted cooling to mod-
erate whole-body hypothermia (32° to 34°C), which has
been shown clinically to improve neurologic recovery
and reduce mortality in post-CA patients [28], might be
the keys to limiting reperfusion organ damage. Our prior
studies showed attenuation of brain and whole-body
ischemic injury after deep hypothermic circulatory arrest
by “controlling” (modifying) the initial CPB reperfusate
[15, 16]. Future studies may use this information to avoid
brain injury by adjusting the pump prime to make it a
controlled reperfusate (whole-body “hot shot”) after pro-
longed CA.
Limitations of this study include the absence of brain
histology to confirm the neurologic damage and the lack
of serial MRI and neurologic deficit score examinations
for 3 to 7 days to determine the ultimate extent of brain
injury. Systemic heparinization before CA, as performed
in our study, is not comparable to the clinical situation
and might have influenced outcomes. However, Pytte
and colleagues [29] demonstrated that pre-CA anticoag-
ulation with enoxaparin (1 mg/kg) had no influence on
hemodynamics or the return of spontaneous circulation
after CPR-ALS after 10 minutes of untreated VF. In
addition, much larger pre-CA heparin doses (700 IU/kg)
were needed to produce favorable effects on survival and
neurologic recovery in dogs subjected to 15 minutes of
normothermic VF and CPB [30]. Finally, the alternative
use of vasopressin and amiodarone (instead of epineph-
rine and lidocaine), which is equally recommended by
the American Heart Association advanced cardiac life
support algorithm, may have further improved the ROSC
and post-CA outcomes observed in our model.
In conclusion, emergency CPB expands the time win-
dow for circulatory resuscitation with improved survival
after prolonged CA of 15 minutes, but fails to limit the
whole-body or brain reperfusion injury. Furthermore,
the treatment option of systemic hyperkalemia for defi-
brillation allows successful cardioversion of intractable
VF with CPB followed by good myocardial recovery and
survival. Future therapeutic strategies need to examine
ways to limit the deleterious effects of the reperfusion-
phenomena on post-CA neurologic injury.
This work was supported by a grant from the National Institutes
of Health (R01-HL-71729-04).
References
1. Madl C, Holzer M. Brain function after resuscitation from
cardiac arrest. Curr Opin Crit Care 2004;10:213–7.
2. El Menyar AA. The resuscitation outcome: revisit the story of
the stony heart. Chest 2005;128:2835–46.
3. Fredriksson M, Herlitz J, Engdahl J. Nineteen years’ experi-
ence of out-of-hospital cardiac arrest in Gothenburg—
reported in Utstein style. Resuscitation 2003;58:37–47.
4. Klouche K, Weil MH, Sun S, et al. Evolution of the stone
heart after prolonged cardiac arrest. Chest 2002;122:1006–11.
5. Weisfeldt ML, Becker LB. Resuscitation after cardiac arrest:
a 3-phase time-sensitive model. JAMA 2002;288:3035–8.
6. Nichol G, Karmy-Jones R, Salerno C, Cantore L, Becker L.
Systematic review of percutaneous cardiopulmonary bypass
for cardiac arrest or cardiogenic shock states. Resuscitation
2006;70:381–94.
7. Safar P, Abramson NS, Angelos M, et al. Emergency cardio-
pulmonary bypass for resuscitation from prolonged cardiac
arrest. Am J Emerg Med 1990;8:55–67.
8. Levine R, Gorayeb M, Safar P, et al. Cardiopulmonary
bypass after cardiac arrest and prolonged closed-chest CPR
in dogs. Ann Emerg Med 1987;16:620–7.
9. Pretto E, Safar P, Saito R, Stezoski W, Kelsey S. Cardiopul-
monary bypass after prolonged cardiac arrest in dogs. Ann
Emerg Med 1987;16:611–9.
10. Ao H, Tanimoto H, Yoshitake A, Moon JK, Terasaki H.
Long-term mild hypothermia with extracorporeal lung and
heart assist improves survival from prolonged cardiac arrest
in dogs. Resuscitation 2001;48:163–74.
11. Kano T, Hashiguchi A, SadanagaM, et al. Cardiopulmonary-
cerebral resuscitation by using cardiopulmonary bypass
through the femoral vein and artery in dogs. Resuscitation
1993;25:265–281.
12. Yoshitake A, Tanimoto H, Ao H, et al. Does veno-arterial
bypass without an artificial lung improve the outcome in
1978 LIAKOPOULOS ET AL Ann Thorac Surg
CPB AFTER PROLONGED CARDIAC ARREST 2010;89:1972–80
A
D
U
LT
C
A
R
D
IA
C
 by Nikola Hristov on October 2, 2010 ats.ctsnetjournals.orgDownloaded from 
dogs undergoing cardiac arrest? Resuscitation 2002;54:
159–66.
13. Reich H, Angelos M, Safar P, Sterz F, Leonov Y. Cardiac
resuscitability with cardiopulmonary bypass after increasing
ventricular fibrillation times in dogs. Ann Emerg Med 1990;
19:887–90.
14. American Heart Association Guidelines for Cardiopulmo-
nary Resuscitation and Emergency Cardiovascular Care:
Part 7.2: Management of Cardiac Arrest. Circulation 2005;
112(Suppl):IV-58–66.
15. Allen BS, Veluz JS, Buckberg GD, Aeberhard E, Ignarro LJ.
Deep hypothermic circulatory arrest and global reperfusion
injury: avoidance by making a pump prime reperfusate—a
new concept. J Thorac Cardiovasc Surg 2003;125:625–32.
16. Castella M, Buckberg GD, Tan Z. Neurologic preservation by
Na$-H$ exchange inhibition prior to 90 minutes of hypo-
thermic circulatory arrest. Ann Thorac Surg 2005;79:646–54.
17. Herlitz J, Engdahl J, Svensson L, et al. Can we define patients
with no chance of survival after out-of-hospital cardiac
arrest? Heart 2004;90:1114–8.
18. Hartz R, LoCicero J III, Sanders JH Jr, et al. Clinical experi-
ence with portable cardiopulmonary bypass in cardiac arrest
patients. Ann Thorac Surg 1990;50:437–41.
19. Sung K, Lee YT, Park PW, et al. Improved survival after
cardiac arrest using emergent autopriming percutaneous
cardiopulmonary support. Ann Thorac Surg 2006;82:651–6.
20. Hill JG, Bruhn PS, Cohen SE, et al. Emergent applications of
cardiopulmonary support: a multiinstitutional experience.
Ann Thorac Surg 1992;54:699–704.
21. Overlie PA. Emergency use of cardiopulmonary bypass.
J Interv Cardiol 1995;8:239–47.
22. Athanasuleas CL, Buckberg GD, Allen BS, Beyersdorf F,
Kirsh MM. Sudden cardiac death: directing the scope of
resuscitation towards the heart and brain. Resuscitation
2006;70:44–51.
23. Kolarova J, Ayoub IM, Yi Z, Gazmuri RJ. Optimal timing for
electrical defibrillation after prolonged untreated ventricular
fibrillation. Crit Care Med 2003;31:2022–8.
24. Gazmuri RJ. Effects of repetitive electrical shocks on pos-
tresuscitation myocardial function. Crit Care Med 2000;28:
N228–32.
25. Buckberg GD. Update on current techniques of myocardial
protection. Ann Thorac Surg 1995;60:805–14.
26. Beyersdorf F, Kirsh M, Buckberg GD, Allen BS. Warm
glutamate/aspartate-enriched blood cardioplegic solution
for perioperative sudden death. J Thorac Cardiovasc Surg
1992;104:1141–7.
27. Arbelaez A, Castillo M, Mukherji SK. Diffusion-weighted
MR imaging of global cerebral anoxia. AJNR Am J Neuro-
radiol 1999;20:999–1007.
28. The Hypothermia After Cardiac Arrest Study Group. Mild
therapeutic hypothermia to improve the neurologic outcome
after cardiac arrest. N Engl J Med 2002;346:549–56.
29. Pytte M, Bendz B, Kramer-Johansen J, et al. Prearrest admin-
istration of low-molecular-weight heparin in porcine cardiac
arrest: hemodynamic effects and resuscitability. Crit Care
Med 2008;36:881–6.
30. Ichinose K, Okamoto T, Tashiro M, Tanimoto H, Terasaki H.
The effects of pre-arrest heparin administration dose for
cardiac arrest model using extracorporeal lung and a heart
assist (ECLHA) in dogs. Resuscitation 2006;69:311–8.
INVITED COMMENTARY
Cardiopulmonary arrest is a leading cause of death in
Western society. Cardiopulmonary resuscitation–
advanced cardiac life support (CPR-ACLS) is widely
thought to be one of the seminal advances in the treat-
ment of heart disease of the 20th century. After nearly 50
years of CPR-ACLS, countless numbers of lives have
been saved, and CPR-ACLS is taught in settings ranging
from the most advanced quaternary medical centers to
local community centers. The benefits are so widely
recognized that defibrillators are found in public settings
ranging from airports to grocery stores throughout the
world. The conundrum is that the benefits of CPR-ACLS
are primarily limited to cardiopulmonary arrest that is
witnessed, and patients who experience prolonged or
unwitnessed cardiac arrest rarely survive.
The report from Liakopoulos and colleagues [1] exam-
ines the utility of emergency cardiopulmonary bypass
(CPB) in cardiac resuscitation after prolonged cardiac
arrest compared with conventional CPR-ACLS. They
additionally examined the effect of supplemental hy-
perkalemic cardiopulmonary arrest in hearts unable to
be cardioverted despite being resuscitated on CPB [1].
CPB in this setting is not a new concept. It has been
investigated many times before, and CPB is thought to be
particularly beneficial for patients who are unable to be
cardioverted after CPR-ACLS in the early “electrical
phase” of cardiac arrest and are in the later “circulatory”
or “metabolic phases” of cardiac arrest [2]. What is
unique here is studying CPB after a prolonged period, 15
minutes, of cardiac arrest to simulate the patient who
experiences an unwitnessed cardiac arrest. Prolonged
periods of cardiac arrest have long been known to reduce
the likelihood that CPR-ACLS will be successful [2]. As
the authors point out, although successful resuscitation
and cardioversion after cardiac arrest can be as high as 40%,
survival is generally only 10% to 15% due to significant
cardiac and brain injury [2]. The longer the downtime, the
greater the risk of brain injury and death [3].
In their porcine fibrillation model, CPB improved sur-
vival and hyperkalemia-induced asystole improved the
chance of defibrillation [1]. The fact that CPB is beneficial
is predictable, and the significance of this report is not
related to this finding. The utility and practicality of CPB
in this setting is another story and worthy of much
discussion. However, what is exciting and a potentially
“disruptive concept” is the use of potassium in patients
who experience a cardiac arrest. Surgeons use potassium
to induce cardiac arrest. We control hyperkalemia post-
operatively to treat arrhythmias, even going as far as
using dialysis to control it. Will this finding cause us to
change our conventional thinking about potassium and
ultimately lead to the addition of intravenous potassium
to the CPR-ACLS protocols in patients who are unable to
be defibrillated early after a cardiac arrest?
Not right now, but perhaps in time. Right now, one has
to ask the question: Why does hyperkalemic arrest allow
successful defibrillation? It may be that hyperkalemic
arrest eliminates electrochemical gradients across the
myocardium to allow defibrillation in an environment of
uniform electrical quiescence. Whatever the mechanism
1979Ann Thorac Surg LIAKOPOULOS ET AL
2010;89:1972–80 CPB AFTER PROLONGED CARDIAC ARREST
© 2010 by The Society of Thoracic Surgeons 0003-4975/$36.00
Published by Elsevier Inc doi:10.1016/j.athoracsur.2010.04.005
A
D
U
LT
C
A
R
D
IA
C
 by Nikola Hristov on October 2, 2010 ats.ctsnetjournals.orgDownloaded from 
DOI: 10.1016/j.athoracsur.2010.02.052 
 2010;89:1972-1979 Ann Thorac Surg
Tan, J. Pablo Villablanca and Georg Trummer 
Oliver J. Liakopoulos, Bradley S. Allen, Gerald D. Buckberg, Nikola Hristov, Zhongtuo
 and Systemic Hyperkalemia
Resuscitation After Prolonged Cardiac Arrest: Role of Cardiopulmonary Bypass
 & Services
Updated Information
 http://ats.ctsnetjournals.org/cgi/content/full/89/6/1972
including high-resolution figures, can be found at: 
 References
 http://ats.ctsnetjournals.org/cgi/content/full/89/6/1972#BIBL
This article cites 30 articles, 13 of which you can access for free at:
 Citations
 s
http://ats.ctsnetjournals.org/cgi/content/full/89/6/1972#otherarticle
This article has been cited by 1 HighWire-hosted articles: 
 Subspecialty Collections
 n
http://ats.ctsnetjournals.org/cgi/collection/extracorporeal_circulatio
 Extracorporeal circulation
 http://ats.ctsnetjournals.org/cgi/collection/cerebral_protection
 Cerebral protection
following collection(s): 
This article, along with others on similar topics, appears in the
 Permissions & Licensing
 .healthpermissions@elsevier.comemail: 
 orhttp://www.us.elsevierhealth.com/Licensing/permissions.jsp
in its entirety should be submitted to: 
Requests about reproducing this article in parts (figures, tables) or
 Reprints
 reprints@elsevier.com
For information about ordering reprints, please email: 
 by Nikola Hristov on October 2, 2010 ats.ctsnetjournals.orgDownloaded from 
